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tachycardia and a holosystolic murmur (grade II) but no 
other findings. 
The patient was then transferred to the pediatric in-
tensive care unit, where she was intubated and mechanical 
ventilation was initiated. Her condition was considered life 
threatening; the patient had severe acute respiratory dis-
tress syndrome and progressive hypoxemia despite venti-
lator treatment, and laboratory findings worsened (Table).
The patient was given transfusions of blood products 
for treatment of anemia and thrombocytopenia. Chest radio-
graph and ultrasound showed an extensive right-side hemo-
thorax. The result of a Zika virus–specific real-time RT-PCR 
was positive (Table). Her clinical condition deteriorated. 
Despite intensive treatment, the patient did not recover and 
died 37 hours later. An autopsy showed hepatic panacinar 
necrosis, erythrophagocytosis of Kupffer cells, and severe 
decrease of splenic lymphoid tissue (functional asplenia) 
with multiple drepanocytes and splenic sequestration, 
but no signs of yellow fever or malaria (online Technical 
Appendix Figure, http://wwwnc.cdc.gov/EID/article/22/5/ 
15-1934-Techapp1.pdf).
Although sickle cell disorders are not common in Co-
lombia, their frequency is higher along the Caribbean coast 
(including Atlántico Department) and 2 times that of the 
rest of Colombia) (6). Although chronic diseases, such as 
sickle cell disorders, are considered to be a risk factor for 
development of severe dengue and chikungunya (7,8), no 
cases have been reported in association with Zika. Reports 
of patients co-infected with DENV and CHIKV are rare, 
few details are available, and mostly restricted to few fatal 
cases of dengue (9). In patients with dengue, deaths might 
be higher among those who have a hemoglobin SC geno-
type, as recently reported (10). Onset of vaso-occlusion in 
persons with sickle cell disorders is often triggered by in-
flammation, as has been reported in DENV infections and 
which probably occurred in our patient (8). This complica-
tion and severe splenic sequestration, detected by autopsy, 
probably caused her death.
In summary, this case indicates that patients with sickle 
cell disorders and suspected arboviral infections should be 
closely monitored. Given current epidemics of Zika virus 
infection in Colombia (746 RT-PCR–confirmed cases and 
11,712 suspected cases during September 22, 2015–Janu-
ary 2, 2016), atypical and severe manifestations and con-
current conditions in patients should be assessed to prevent 
additional deaths (2).
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To the Editor: Zika virus is an arthropodborne mem-
ber of the genus Flavivirus of the Spondweni serocomplex 
and is transmitted by Aedes mosquitoes (primarily Ae. ae-
gypti in urban and periurban cycles). Zika virus emerged 
in Africa and has caused outbreaks of febrile disease that 
clinically resemble dengue fever and other arboviral dis-
eases (1) but has been linked to neurologic syndromes and 
congenital malformation (2). Outbreaks have been reported 
in the Yap islands of the Federated States of Micronesia 
(3), French Polynesia (4), and Oceania; Brazil is currently 
experiencing the first reported local transmission of Zika 
virus  in the Americas (5).
The future spread of Zika virus  is unpredictable, but 
the history of the virus has been reminiscent of chikungunya 
virus (CHIKV), which reemerged in Africa and now circu-
lates on all inhabited continents and is a major global health 
problem. Zika virus  has been found in Colombia and is like-
ly following the path of CHIKV, which reached the coun-
try in August 2014 (6). The virus co-circulates with other 
Ae. aegypti–transmitted arboviruses, including dengue virus 
(DENV) and yellow fever virus. We report Zika virus  infec-
tion in Colombia and a recent ongoing outbreak in Sincelejo, 
Colombia, with resulting illness characterized by maculo-
papular rash, fever, myalgia/arthralgia, and conjunctivitis.
During October–November 2015, a total of 22 patients 
received a presumptive diagnosis of an acute viral illness by 
emergency department physicians at the Centro de Diagnos-
tico Medico-Universidad de Sucre in Sincelejo. The patients 
began treatment for a dengue-like illness, and blood samples 
were obtained for diagnosis. The samples were analyzed 
at the Universidad de Sucre by using reverse transcription 
PCR (RT-PCR) to detect DENV, CHIKV, or Zika virus. Viral 
RNA was extracted from the serum samples by using the ZR 
Viral RNA Kit (Zymo Research, Irvine, CA, USA); reverse 
transcription was performed by using the Protoscript First 
Strand cDNA Synthesis Kit (New England Biolabs, Ipswich, 
MA, USA). Amplicons were produced by using the OneTaq 
Quick-Load 2X Master Mix (New England Biolabs) with 
primers specific to DENV (7), CHIKV (forward: 5′-CGC-
CAACATTCTGCTTACAC-3′; reverse: 5′-AGGATGCCG-
GTCATTTGAT-3′), and Zika virus. The CHIKV amplifica-
tion target was 649 bp of nonstructural protein 1 (NS1). A 
positive PCR for a partial region of the envelope (E) gene 
with primers ZIKVENVF and ZIKVENVR (8) was consid-
ered indicative of Zika virus infection. Zika virus primers 
specific for the E gene and NS1 were designed and used to 
amplify the E gene and NS1 for phylogenetic analyses, and 
amplicons were produced by using the OneTaq One-Step 
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Figure. Majority-rule consensus tree based on Zika virus envelope and nonstructural protein 1 gene sequences (2,604 nt) of isolates 
from patients in Sincelejo, Colombia, October–November 2015, compared with reference isolates. The tree was constructed on the 
basis of Bayesian phylogenetic analysis with 8 million generations and a general time-reversible substitution model using MrBayes 
software version 3.2 (http://mrbayes.sourceforge.net). Numbers to the right of nodes represent posterior probabilities for corresponding 
clades. Samples sequenced in this study are in bold, and sequences are listed with GenBank accession numbers and are coded 
as accession no./strain/country/year of isolation when all information was available. The Colombia sequences are grouped with the 
Asian lineage of Zika virus. The tree was rooted with the Spondweni virus isolated in South Africa as the outgroup. Scale bar indicates 
nucleotide substitutions per site.
RT-PCR Kit (New England Biolabs). E gene and NS1 PCR 
products were sequenced at the University of Wisconsin–
Madison Biotechnology Center (Madison, WI, USA).
Samples from all patients were negative by RT-PCR 
for DENV and CHIKV; samples from 9 (41%) patients 
were positive for Zika virus. Among those 9 patients, 7 
(78%) were male; median age was 23; and none had a his-
tory of international travel. Zika virus was analyzed by se-
quencing the E gene and NS1 of 2 isolates. Phylogenetic 
analyses rooted with Spondweni virus showed that the Zika 
virus sequences (GenBank accession nos. KU646827 and 
KU646828) belonged to the Asian lineage (Figure) and 
were closely related to strains isolated during the 2015 out-
break in Brazil (5). The sequences also showed 99% iden-
tity with sequences from a Zika virus isolate from French 
Polynesia (GenBank accession no. KJ776791) (9). These 
data suggest that Zika virus circulating in Colombia could 
have been imported from Brazil, most likely as a result of 
tourism activities on Colombia’s northern coast, where the 
first reported case was identified (the state of Bolivar).
We report Zika virus infection in Colombia in associa-
tion with an ongoing outbreak of acute maculoexantematic 
illness. Since detection of Zika virus in Sincelejo, a total of 
13,500 cases have been identified in 28 of the country’s 32 
territorial entities (10), all of which have abundant popula-
tions of Ae. aegypti mosquitoes and co-circulation of DENV 
and CHIKV. These circumstances highlight the need for ac-
curate laboratory diagnostics and suggest that monitoring 
whether the virus spreads into neighboring countries (e.g., 
Ecuador, Peru, Venezuela, and Panama) is imperative.
We thank the University of Wisconsin–Madison for partially 
funding this study. E.C. was supported by the University of 
Wisconsin–Madison Global Health Institute.
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To the Editor: To facilitate early recognition of 
Ebola virus disease (EVD), the New York City Depart-
ment of Health and Mental Hygiene (DOHMH) actively 
monitored persons who had recently traveled from an 
EVD-affected country (1,2). Clinical manifestations of 
EVD are nonspecific and can resemble common travel-
associated illnesses, such as malaria and influenza, both 
of which are potentially preventable through use of cer-
tain health precautions (3,4). Given the consequences of 
missing an EVD diagnosis, symptomatic persons under 
active monitoring who actually have non-EVD illnesses 
are often first isolated and tested for Ebola virus, which 
can delay appropriate care for the true cause of their ill-
ness and consume substantial resources. We evaluated 
the health precautions taken by persons traveling to 
EVD-affected countries.
During March 16, 2015–December 29, 2015 (the last 
day of EVD active monitoring by DOHMH), persons who 
underwent active EVD monitoring by DOHMH and who 
reported living in the United States for most of the previous 
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